...
首页> 外文期刊>The Journal of laboratory and clinical medicine >Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo (see comments)
【24h】

Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo (see comments)

机译:活性氧在体外和体内增强糖尿病大鼠肾小球内皮素-1的产生(见评论)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Both reactive oxygen species (ROS) and endothelin-1 (ET- 1) have been implicated in the pathophysiology of diabetic nephropathy. The interrelationship between them, however, has not been documented in this disease. To determine whether ROS regulates ET-1 production in diabetic kidneys, we examined the in vitro and in vivo effects of ROS donors and scavengers on ET-1 production of diabetic rat glomeruli. For in vitro study, the glomeruli were isolated with a sieving method from streptozotocin-induced diabetic rats and killed at 1 week, 1 month, and 3 months, respectively. Superoxide was measured by a spectrophotometer, and ET-1 was measured by radioimmunoassay. The results demonstrated that the basal production levels of superoxide and ET-1 were higher in diabetic glomeruli than in normal glomeruli in vitro. There was a positive correlation between the production of superoxide and ET-1 in diabetic glomeruli. The basal ET-1 production was markedly attenuated by ROS scavengers including superoxide dismutase, catalase, dimethyl sulfoxide, and deferoxamine in diabetic glomeruli. Exogenous ROS generated by xanthine/xanthine oxidase significantly enhanced ET-1 generation by both diabetic and normal glomeruli. A high glucose concentration (500 mg/dL) in vitro increased ET-1 production by normal glomeruli but not diabetic glomeruli, and insulin partly suppressed ET- 1 production by diabetic glomeruli. The in vivo study demonstrated that when diabetic rats were injected daily with superoxide dismutase or catalase after diabetes was induced, the basal production of ET-1 was markedly attenuated after 1 week and 1 month, respectively. These results indicate that exogenously or endogenously derived ROS can enhance ET-1 production by diabetic rat glomeruli and that ROS scavengers suppress ET- 1 production both in vitro and in vivo. The effects of ROS on ET-1 production of diabetic glomeruli may be partly caused by the effect of hyperglycemia or insulin deficiency.
机译:活性氧(ROS)和内皮素1(ET-1)都与糖尿病性肾病的病理生理有关。然而,在这种疾病中尚未记录它们之间的相互关系。为了确定ROS是否调节糖尿病肾中ET-1的产生,我们检查了ROS供体和清除剂对糖尿病大鼠肾小球ET-1产生的体外和体内作用。为了进行体外研究,用筛分法从链脲佐菌素诱导的糖尿病大鼠中分离肾小球,并分别在第1周,第1个月和第3个月将其杀死。通过分光光度计测量超氧化物,通过放射免疫测定法测量ET-1。结果表明,在体外,糖尿病肾小球中超氧化物和ET-1的基础产生水平高于正常肾小球。糖尿病肾小球中超氧化物的生成与ET-1呈正相关。糖尿病肾小球中的ROS清除剂(包括超氧化物歧化酶,过氧化氢酶,二甲基亚砜和去铁胺)显着减弱了基础ET-1的产生。黄嘌呤/黄嘌呤氧化酶产生的外源性ROS显着增强了糖尿病和正常肾小球的ET-1生成。体外的高葡萄糖浓度(500 mg / dL)增加了正常肾小球的ET-1产生,但没有增加糖尿病肾小球,胰岛素部分抑制了糖尿病肾小球的ET-1产生。体内研究表明,当诱发糖尿病后每天向糖尿病大鼠注射超氧化物歧化酶或过氧化氢酶时,分别在1周和1个月后ET-1的基础产生显着减弱。这些结果表明,外源或内源性ROS可以增强糖尿病大鼠肾小球的ET-1产生,并且ROS清除剂在体外和体内均抑制ET-1的产生。 ROS对糖尿病肾小球ET-1产生的影响可能部分由高血糖或胰岛素缺乏的影响引起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号